Furthermore, a recent study also showed that high-risk HPV infections went together with mutations in PIK3CA, EP300, NF1, and RB1 in samples from benign tonsils, suggesting these mutations to be potential biomarkers to identify the cancer progression risk [30]. This evidence concerns the gene RB1 and cancer.